Nanjing Drum Tower Hospital
Nanjing Drum Tower Hospital
News Article | April 24, 2017
PARIS--(BUSINESS WIRE)--EOS imaging (Paris:EOSI)(Euronext, FR0011191766 – EOSI), the pioneer in 2D/3D orthopedic medical imaging, today announced the first two installations of EOS systems in China at Nanjing Drum Tower Hospital and Ruijin Hospital. Nanjing Drum Tower Hospital, Affiliated Hospital of Nanjing University Medical School, provides service to approximately 80 million residents of Jiangsu Province. The hospital is a reference center in China for adult and pediatric orthopedic and spi
News Article | April 24, 2017
PARIS--(BUSINESS WIRE)--Regulatory News: EOS imaging (Paris:EOSI) (Euronext, FR0011191766 – EOSI), the pioneer in 2D/3D orthopedic medical imaging, today announced the first two installations of EOS systems in China at Nanjing Drum Tower Hospital and Ruijin Hospital. Nanjing Drum Tower Hospital, Affiliated Hospital of Nanjing University Medical School, provides service to approximately 80 million residents of Jiangsu Province. The hospital is a reference center in China for adult and pediatric
Heng H.,Nanjing Normal University |
Wang R.,Nanjing Drum Tower Hospital |
Wang R.,Nanjing Medical University
Photonic Sensors | Year: 2017
Optical metamaterials can concentrate light into extremely tiny volumes to enhance their interaction with quantum objects. In this paper, a cylindrical microcavity based on the Au-dielectric-Au sandwiched structure is proposed. Numerical study shows that the cylindrical microcavity has the strong ability of localizing light and confining 103– − 104–fold enhancement of the electromagnetic energy density, which contains the most energy of the incoming light. The enhancement factor of energy density G inside the cavity shows the regularities as the change in the thickness of the dielectric slab, dielectric constant, and the radius of gold disk. At the normal incidence of electromagnetic radiation, the obtained reflection spectra operate in the range from 4.8 μm to 6 μm and with the absorption efficiency C (C=1–Rmin), which can reach 99% by optimizing the structure’s geometry parameters, and the dielectric constant. Due to the symmetry of the cylindrical microcavities, this structure is insensitive to the polarization of the incident wave. The proposed optical metamaterials will have potential applications in the surface enhanced spectroscopy, new plasmonic detectors, bio-sensing, solar cells, etc. © 2017, The Author(s).
Yang D.,Nanjing Southeast University |
Lu X.,Nanjing Southeast University |
Hong Y.,Nanjing Drum Tower Hospital |
Xi T.,Peking University
Biomaterials | Year: 2013
To explore molecular mechanism of mediation of adsorbed proteins to cell adhesion and growth on biomaterials, this study examined endothelial cell adhesion, morphology and viability on bare and titanium nitride (TiN) coated nickel titanium (NiTi) alloys and chitosan film firstly, and then identified the type and amount of serum proteins adsorbed on the three surfaces by proteomic technology. Subsequently, the mediation role of the identified proteins to cell adhesion and growth was investigated with bioinformatics analyses, and further confirmed by a series of cellular and molecular biological experiments. Results showed that the type and amount of adsorbed serum proteins associated with cell adhesion and growth was obviously higher on the alloys than on the chitosan film, and these proteins mediated endothelial cell adhesion and growth on the alloys via four ways. First, proteins such as adiponectin in the adsorbed protein layer bound with cell surface receptors to generate signal transduction, which activated cell surface integrins through increasing intracellular calcium level. Another way, thrombospondin 1 in the adsorbed protein layer promoted TGF-β signaling pathway activation and enhanced integrins expression. The third, RGD sequence containing proteins such as fibronectin 1, vitronectin and thrombospondin 1 in the adsorbed protein layer bound with activated integrins to activate focal adhesion pathway, increased focal adhesion formation and actin cytoskeleton organization and mediated cell adhesion and spreading. In addition, the activated focal adhesion pathway promoted the expression of cell growth related genes and resulted in cell proliferation. The fourth route, coagulation factor II (F2) and fibronectin 1 in the adsorbed protein layer bound with cell surface F2 receptor and integrin, activated regulation of actin cytoskeleton pathway and regulated actin cytoskeleton organization. © 2013 Elsevier Ltd.
Huang Q.,Nanjing Drum Tower Hospital |
Huang Q.,Changzhou Second Hospital |
Huang Q.,Harvard University
Journal of Digestive Diseases | Year: 2017
Gastric cardiac carcinoma (GCC) was and is considered as a part of esophageal adenocarcinoma (EAC) and staged with the rules for EAC. This may change. Recent comprehensive integrated genomic investigations on gastric and esophageal carcinomas discovered similar chromosomal instability profiles in these two groups of carcinomas with a gradual increasing gradient from the lowest percentage in the distal gastric antrum to a high level in the proximal gastric cardia, and to the peak of almost 100% in EAC. Therefore, most GCCs and EAC share similar chromosomal instable features of gastric carcinoma and should be grouped as a single disease entity because EAC may be the proximal extension of chromosomal instable GCCs. This breakthrough discovery in genomic characteristics of GCC and EAC would dramatically change the strategy on how patients should be appropriately managed clinically and also greatly help future investigation on detailed molecular pathogenetic mechanisms of GCC, leading to cure this fatal cancer. © 2017 Chinese Medical Association Shanghai Branch, Chinese Society of Gastroenterology, Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine and John Wiley & Sons Australia, Ltd
Chen S.,Wuhan University |
Shi H.,Tongji University |
Zou X.,Nanjing Drum Tower Hospital |
Luo H.,Wuhan University
Pancreas | Year: 2010
Objectives: The role of prophylactic ulinastatin in the prevention of post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis is debated. A meta-analysis of all published randomized clinical trials was performed to evaluate the efficacy of ulinastatin on post-ERCP pancreatitis. Methods: Searches were conducted in multiple databases composed of PubMed, EMBASE, the Cochrane Library, the Science Citation Index Expanded, and the China National Knowledge Infrastructure series full-text database. Primary outcome was post-ERCP pancreatitis, with or without hyperamylasemia. Results: Seven randomized clinical trials fulfilling the inclusion criteria were selected for meta-analysis, 5 comparing ulinastatin with placebo and 2 for ulinastatin versus gabexate. The incidence of post-ERCP pancreatitis was reduced by ulinastatin (odds ratio, 0.53; 95% confidence interval, 0.31-0.89; P = 0.02; test for heterogeneity: I2 = 0%; P = 0.51), so was the event of hyperamylasemia (odds ratio, 0.42; 95% confidence interval, 0.30-0.59; P < 0.00001; test for heterogeneity: I2 = 13%; P = 0.33). Subsequent sensitivity and subgroup analyses produced conflicting results. Conclusions: Ulinastatin shows to be of value on preventing post-ERCP pancreatitis and hyperamylasemia for patients in average risk, when given intravenously at a dose of not less than 150,000 U, just before ERCP. More high-quality trials are needed for further confirmation. © 2010 by Lippincott Williams & Wilkins.
Huang Q.,Nanjing Drum Tower Hospital |
Huang Q.,Harvard University
World Journal of Gastroenterology | Year: 2012
Carcinoma of the gastroesophageal junction (GEJ) is defined as carcinoma that crosses the GEJ line, irrespective of where the tumor epicenter is located. This group of cancer is rare but controversial. Based on study results from the majority of epidemiologic and clinicopathologic investigations carried out in Western countries, this cancer is believed to arise from Barrett's esophagus (BE) and includes both distal esophageal and proximal gastric carcinomas because of similar characteristics in epidemiology, clinicopathology, and molecular pathobiology in relation to BE. As such, the most recent American Joint Committee on Cancer staging manual requires staging all GEJ carcinomas with the rule for esophageal adenocarcinoma (EA). This mandate has been challenged recently by the data from several studies carried out mainly in Chinese patients. The emerging evidence derived from those studies suggests: (1) both BE and EA are uncommon in the Chinese population; (2) almost all GEJ cancers in Chinese arise in the proximal stomach and show the features of proximal gastric cancer, not those of EA; (3) application of the new cancer staging rule to GEJ cancer of Chinese patients cannot stratify patients' prognosis effectively; and (4) prognostic factors of GEJ cancer in Chinese are similar, but not identical, to those of EA. In conclusion, the recent evidence suggests that GEJ cancer in Chinese shows distinct clinicopathologic characteristics that are different from EA. Further investigations in molecular pathology may help illustrate the underlying pathogenesis mechanisms of this cancer in Chinese patients and better manage patients with this fatal disease. © 2012 Baishideng. All rights reserved.
Ling T.,Nanjing Drum Tower Hospital |
Guo H.,Nanjing Drum Tower Hospital |
Zou X.,Nanjing Drum Tower Hospital
Journal of Gastroenterology and Hepatology (Australia) | Year: 2014
Background and Aim: To investigate the effectiveness of peroral endoscopic myotomy (POEM) surgery in achalasia patients with failure of prior pneumatic dilation (PD). Methods: Twenty-one patients with a history of failed PD were prospectively recruited as the case group, and 30 patients with no history of prior treatment for achalasia were included as the control group. Outcome of POEM procedures was evaluated through esophageal manometry, timed barium esophagogram and short form 36 (SF-36) questionnaires, which were performed before surgery, at 5 days after surgery and at the last follow-up, respectively. Relief of patients' symptoms was considered as the primary outcome. Secondary outcomes included lower esophageal sphincter pressure, esophageal emptying, quality of life of the patient, and procedure-related complications. Results: The two groups were matched in terms of age, gender, body mass index, and results of preoperative examinations. For patients with failed PD, it was observed that Eckardt score, lower esophageal sphincter pressure, and height of the barium column were significantly decreased after POEM surgery. Besides, the mean physical component summary and mental component summary of patients at the final follow were significantly higher than those before surgery. Complications that occurred during the surgery included three cases of subcutaneous emphysema (14.3%) and one case of pneumothorax (4.8%). Patients with failed PD were found to have the significantly longer operation time than the control group. There was no significant difference between the two groups in terms of surgical outcome at the final follow-up. Conclusions: POEM is a promising therapeutic modality for achalasia patients who have failed to respond to PD therapy. Previous dilation procedures might have no obvious influence on the efficacy of POEM surgery. © 2014 Journal of Gastroenterology and Hepatology Foundation and Wiley Publishing Asia Pty Ltd.
Cao B.,Nanjing Drum Tower Hospital |
Shi Q.,Nanjing Drum Tower Hospital |
Wang W.,Nanjing Drum Tower Hospital
Journal of Thoracic Disease | Year: 2015
Background: High expression of Sirtuin type 1 (SIRT1) exists in some cancer cells. However, it is still unclear whether SIRT1 affects the sensitivity of esophageal cancer cells to cisplatin. This study was designed to explore the relationship between SIRT1 expression and resistance of esophageal squamous cell carcinoma (ESCC) cells to cisplatin and reveal the underlying mechanism. Methods: The tissue samples of 68 ESCC patients were collected from Nanjing Drum Tower Hospital, China. All the patients had undergone cisplatin based combination chemotherapy. The expression of SIRT1and Noxa in tissue samples were analyzed by quantitative real-time reverse PCR (qRT-PCR) and Western blot. Human ESCC cell line (ECa9706 cells) was cultured and a cisplatin-resistant subline (ECa9706-CisR cells) was established by continuous exposure to cisplatin at different concentrations. The expression of SIRT1 and Noxa in both cell lines was analyzed by qRT-PCR and Western blot. siRNA technology was utilized to down-regulate the SIRT1 expression in ECa9706-CisR cells. The influence of SIRT1 silence on sensitivity of ECa9706-CisR cells to cisplatin was confirmed using CCK-8 assay and flow cytometry. Furthermore, the level change of Noxa after SIRT1 silence in ECa9706-CisR cells was determined by qRT-PCR and Western blot. Result: SIRT1 and Noxa expression in chemo-resistant patients was significantly increased and decreased respectively, compared with chemo-sensitive patients. SIRT1 expression in ECa9706-CisR cells was significantly increased with a lower Noxa level, compared with normal ECa9706 cells. Cisplatin 5 μM could cause proliferation inhibition, G2/M phase arrest and apoptosis in ECa9706-CisR cells and these effects could be enhanced dramatically by SIRT1 silencing. Moreover, Noxa expression was increased after treated with SIRT1 siRNA. Conclusions: Over-expression of SIRT1 may cause resistance of ESCC cells to cisplatin through the mechanism involved with Noxa expression. © Journal of Thoracic Disease.
News Article | April 13, 2016
Nanozymes are novel nanomaterials with enzyme mimicking activities, which are superior to natural enzymes and even conventional artificial enzymes. They have attracted considerable attention because they offer the possibility of lowered cost, improved stability, and excellent recyclability. However, the specificity and catalytic activity of current nanozymes are still far lower than that of their natural counterparts, which in turn have limited their broad applications. To tackle this challenge, Professor Wei and his team from Nanjing University, Nanjing Drum Tower Hospital, and Emory University now report the design and development of integrated nanozymes by confining two cascade catalysts inside a nanostructured metal-organic framework. A major advantage of this integrated design is that the first enzymatic reaction occurs in nanoscale proximity to the second enzyme, so products of the first reaction can be used immediately as substrates for the second reaction, thus overcoming the problems of diffusion-limited kinetics and product instability. Specifically, a molecular catalyst (e.g., hemin) and a natural enzyme (e.g., glucose oxidase, GOx) have been simultaneously assembled inside a nanoscaled zeolitic imidazolate framework (ZIF-8), and the resulting GOx/hemin@ZIF-8 integrated nanozymes show numerous merits such as enhanced catalytic activity and improved thermal stability. Quantitative enzymatic studies indicate that their integrated nanozymes are able to provide greater than 600 percent enhancement in catalytic activity relative to a simple mixture of hemin@ZIF-8 and GOx@ZIF-8. Their strategy is general and has also been applied to other enzymes (e.g., lactate oxidase/hemin@ZIF-8) and multiple catalysts (e.g., invertase/GOx/hemin@ZIF-8). More excitingly, this dramatic improvement in catalytic activity has allowed them to construct an integrative detection platform by combining the nanozymes with microdialysis and microfluidic techniques. The platform has been successfully employed for the in vivo monitoring of neurochemicals such as striatum glucose in the brains of living rats following ischemia/reperfusion. Considering the vast numbers of combinations of nanozymes with other artificial enzymes and/or natural enzymes, their current strategy and platform might be extended for a wide range of targets associated with many critical diseases in other living animals and even human beings. Explore further: Structures made of polymer chains allow organic catalysts to work in water More information: Hanjun Cheng et al. Integrated nanozymes with nanoscale proximity for neurochemical monitoring in living brains , Analytical Chemistry (2016). DOI: 10.1021/acs.analchem.6b00975